0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Editorials |

Aspirin for Prevention and Treatment of Cardiovascular Disease

Shamir R. Mehta, MD, MSc
[+] Article and Author Information

From McMaster University, Hamilton General Hospital, Hamilton, Ontario L8L 2X2, Canada.


Potential Financial Conflicts of Interest: None disclosed.

Requests for Single Reprints: Shamir R. Mehta, MD, MSc, McMaster University, Hamilton General Hospital, 237 Barton Street East, Hamilton, Ontario L8L 2X2, Canada; e-mail: smehta@mcmaster.ca.


Ann Intern Med. 2009;150(6):414-416. doi:10.7326/0003-4819-150-6-200903170-00011
Text Size: A A A

Millions of persons worldwide take aspirin on a daily basis for the prevention and treatment of cardiovascular disease. Aspirin inhibits platelets by irreversibly inactivating cyclooxygenase-1, thereby blocking the generation of thromboxane A2, a potent vasoconstrictor and platelet agonist. Despite decades of research, some fundamental questions about aspirin have yet to be definitively answered. In this issue, 2 studies (12) shed light on 2 of these key questions: What is the optimal dose of aspirin to administer to patients for secondary prevention and treatment of established cardiovascular disease and in whom, and when should aspirin be used for prevention of cardiovascular events in persons with no history of cardiovascular disease (primary prevention)?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)